Amedisys, Inc.
AMED
$91.91
$0.330.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.78% | 5.65% | 6.91% | 2.70% | 1.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.78% | 5.65% | 6.91% | 2.70% | 1.55% |
| Cost of Revenue | 7.22% | 8.32% | 9.91% | 2.07% | 1.34% |
| Gross Profit | 1.63% | 2.25% | 3.42% | 3.52% | 1.83% |
| SG&A Expenses | 1.50% | 2.77% | 1.14% | -0.27% | 3.24% |
| Depreciation & Amortization | 10.21% | 7.62% | -7.17% | -3.87% | -20.78% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.07% | 6.21% | 6.32% | 1.14% | 1.83% |
| Operating Income | 1.40% | -0.41% | 12.00% | 21.32% | -1.53% |
| Income Before Tax | -165.85% | -23.61% | 179.11% | -21.56% | -29.36% |
| Income Tax Expenses | -38.19% | 1.15% | -8.73% | 28.91% | 3.96% |
| Earnings from Continuing Operations | -234.17% | -35.53% | 140.47% | -41.41% | -39.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1,601.32% | 15.41% | -232.04% | -157.57% | 76.61% |
| Net Income | -205.48% | -34.86% | 140.24% | -42.96% | -39.08% |
| EBIT | 1.40% | -0.41% | 12.00% | 21.32% | -1.53% |
| EBITDA | 2.83% | 1.09% | 11.08% | 19.74% | -0.09% |
| EPS Basic | -205.10% | -35.10% | 140.08% | -43.15% | -39.31% |
| Normalized Basic EPS | 32.49% | 6.09% | -4.86% | 31.83% | -1.35% |
| EPS Diluted | -206.83% | -35.44% | 139.77% | -42.86% | -39.75% |
| Normalized Diluted EPS | 33.63% | 5.50% | -5.84% | 30.94% | -1.92% |
| Average Basic Shares Outstanding | 0.36% | 0.37% | 0.39% | 0.34% | 0.38% |
| Average Diluted Shares Outstanding | -0.49% | 0.93% | 1.44% | 1.03% | 0.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |